Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?

Figure 1

Involvement of CD36 in the metastatic process, related to the main three components of any tumour niche: the tumour cells, stromal cells, and vascularisation. CD36 expression in tumours prone to metastasis is different in each compartment, as demonstrated by animal models and pathology studies in patient samples.